Last reviewed · How we verify
NCT04358939
Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19)
NA trial testing Prone decubitus in Acute Respiratory Distress Syndrome in 405 participants. Completed in 21 February 2021.
21 February 2021
Quick facts
| Lead sponsor | University Hospital, Tours |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 405 |
| Start date | 27 April 2020 |
| Primary completion | 21 February 2021 |
| Estimated completion | 21 February 2021 |
| Sites | 24 locations across France |
Drugs / interventions tested
- Prone decubitus
Conditions studied
- Acute Respiratory Distress Syndrome — all drugs for Acute Respiratory Distress Syndrome →
- COVID-19 — all drugs for COVID-19 →
Sponsor
University Hospital, Tours
Who can join
18 and older, any sex, with Acute Respiratory Distress Syndrome or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute Respiratory Distress Syndrome (ARDS) induces high mortality, particularly in the context of COVID-19 disease. Preliminary data from patients with ARDS related to COVID-19 disease appear to show significant effectiveness of prone positioning in intubated patients in terms of oxygenation as well as nasal high flow therapy before intubation. It should be noted that in Jiangsu province, secondarily affected, nasal high flow combined with the prone position was successfully integrated into care protocols. The investigators hypothesize that the combined application of nasal high flow and prone positioning can significantly improve the outcome of patients suffering from COVID-19 pneumonia by reducing the need for tracheal intubation and associated therapeutics such as sedation and paralysis, resulting in both individual and collective benefits in terms of use of scarce critical care resources. Investigators hypothesize that the combined application of nasal high-flow and prone positioning can significantly improve the outcome of patients suffering from COVID-19 pneumonia by reducing the need for intubation and associated therapeutics such as sedation and paralysis, resulting in both individual and collective benefits in terms of use of scarce critical care resources.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, et al · · 2021 · cited 271× · PMID 34425070 · DOI 10.1016/s2213-2600(21)00356-8 -
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives.
Touchon F, Trigui Y, Prud'homme E, Lefebvre L, et al · · 2021 · cited 40× · PMID 33952601 · DOI 10.1183/16000617.0022-2021 -
Prone position in COVID 19-associated acute respiratory failure.
Kharat A, Simon M, Guérin C. · · 2022 · cited 24× · PMID 34750322 · DOI 10.1097/mcc.0000000000000900 -
Prone positioning in conscious patients on medical wards: A review of the evidence and its relevance to patients with COVID-19 infection.
Chad T, Sampson C. · · 2020 · cited 16× · PMID 32503800 · DOI 10.7861/clinmed.2020-0179 -
Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial.
Tavernier E, McNicholas B, Pavlov I, Roca O, et al · · 2020 · cited 14× · PMID 33177145 · DOI 10.1136/bmjopen-2020-041520 -
Awake prone positioning for patients with COVID-19 pneumonia in intensive care unit: A systematic review and meta-analysis.
Huang HB, Yao Y, Zhu YB, Du B. · · 2022 · cited 2× · PMID 36160173 · DOI 10.3389/fmed.2022.984446 -
What is the most adequate non-invasive oxygen support for acute hypoxaemic respiratory failure due to COVID-19?
Frat JP, Thille AW, Arrivé F, Lujan M, et al · · 2021 · cited 1× · PMID 34157444 · DOI 10.1016/j.accpm.2021.100909 -
[Noninvasive ventilation and positional therapy in COVID-19 : Case report and literature review].
Sellmann T, Maurer C, Thal SC. · · 2021 · cited 1× · PMID 33961076 · DOI 10.1007/s00101-021-00973-0
Verify or expand the search:
- PubMed search for NCT04358939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Respiratory Distress Syndrome
Currently open trials in the same condition.
- NCT07284888 — Practices of Prone Positioning Ventilation in Patients With Moderate-to-Severe ARDS in Intensive Care Units: A Registry- · recruiting
- NCT07289711 — Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter C · recruiting
- NCT07326215 — A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+ · NA · recruiting
- NCT06919484 — The Physiological Effect of RCexp on Ventilation/Perfusion Distribution · recruiting
- NCT07126964 — Extended Prone Positioning for Intubated ARDS · NA · recruiting
Other University Hospital, Tours trials
Trials by the same sponsor.
- NCT07452978 — Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence · Phase 2 · not yet recruiting
- NCT07443800 — Comorbidity Between Attention Deficit Hyperactivity Disorder and Fibromyalgia · NA · not yet recruiting
- NCT07251530 — Communication Enhancement Among Ventilated Patients in Intensive Care · not yet recruiting
- NCT07189338 — Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation · NA · not yet recruiting
- NCT07054112 — Efficacy of Live Online Course Mindfulness Program on Perceived Fatigue in Hemodialysis Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04358939 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Tours
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing